Legal Status

This site displays a prototype of a “Web 2.0” version of the daily Federal Register. It is not an official legal edition of the Federal Register, and does not replace the official print version or the official electronic version on GPO’s govinfo.gov.

The documents posted on this site are XML renditions of published Federal Register documents. Each document posted on the site includes a link to the corresponding official PDF file on govinfo.gov. This prototype edition of the daily Federal Register on FederalRegister.gov will remain an unofficial informational resource until the Administrative Committee of the Federal Register (ACFR) issues a regulation granting it official legal status. For complete information about, and access to, our official publications and services, go to About the Federal Register on NARA's archives.gov.

The OFR/GPO partnership is committed to presenting accurate and reliable regulatory information on FederalRegister.gov with the objective of establishing the XML-based Federal Register as an ACFR-sanctioned publication in the future. While every effort has been made to ensure that the material on FederalRegister.gov is accurately displayed, consistent with the official SGML-based PDF version on govinfo.gov, those relying on it for legal research should verify their results against an official edition of the Federal Register. Until the ACFR grants it official status, the XML rendition of the daily Federal Register on FederalRegister.gov does not provide legal notice to the public or judicial notice to the courts.

Legal Status

Notice

Gastrointestinal Drugs Advisory Committee; Notice of Postponement of Meeting

A Notice by the Food and Drug Administration on 09/28/2012

Document Details
Published Content - Document Details

Agencies

Department of Health and Human Services

Food and Drug Administration

Agency/Docket Number

Docket No. FDA-2012-N-0001

Document Citation

77 FR 59624

Document Number

2012-23885

Document Type

Notice

Page

59624 (1 page)

Publication Date

09/28/2012

Published Content - Document Details

PDF
Official Content
- View printed version (PDF)
Official Content
Document Details
Published Content - Document Details

Agencies

Department of Health and Human Services

Food and Drug Administration

Agency/Docket Number

Docket No. FDA-2012-N-0001

Document Citation

77 FR 59624

Document Number

2012-23885

Document Type

Notice

Page

59624 (1 page)

Publication Date

09/28/2012

Published Content - Document Details
Table of Contents
Enhanced Content - Table of Contents
This table of contents is a navigational tool, processed from the headings within the legal text of Federal Register documents. This repetition of headings to form internal navigation links has no substantive legal effect.
Enhanced Content - Table of Contents

Related Documents

Enhanced Content - Related Documents

FederalRegister.gov uses the agency dockets published with the document to display related documents.

Docket No. FDA-2012-N-0001 (141 Documents)
Date		Action	Title
	01/25/2013	Notice.	Vaccines and Related Biological Products Advisory Committee; Notice of Meeting
	01/04/2013	Notice.	Advisory Committee for Reproductive Health Drugs; Notice of Meeting
	01/04/2013	Notice.	Medical Imaging Drugs Advisory Committee; Notice of Meeting
	01/02/2013	Notice.	Advisory Committees; Tentative Schedule of Meetings for 2013
	12/26/2012	Notice of public workshop.	Public Workshop on Minimal Residual Disease; Public Workshop
	12/26/2012	Notice of public workshop.	Public Workshop on Minimal Residual Disease; Public Workshop
	12/14/2012	Notice.	Pulmonary-Allergy Drugs Advisory Committee; Notice of Meeting
	12/13/2012	Notice; correction.	Neurological Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting; Correction
	12/10/2012	Notice.	Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting
	12/10/2012	Notice.	Cellular, Tissue and Gene Therapies Advisory Committee; Notice of Meeting
	12/07/2012	Notice.	Neurological Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	12/07/2012	Notice.	Request for Notification From Industry Organizations Interested in Participating in the Selection Process for Nonvoting Industry Representatives and Request for Nominations for Nonvoting Industry Representatives on Public Advisory Panels
	12/04/2012	Notice.	Request for Notification From Industry Organizations Interested in Participating in the Selection Process for Nonvoting Industry Representatives and Request for Nominations for Nonvoting Industry Representatives on the Device Good Manufacturing Practice Advisory Committee
	10/12/2012	Notice.	Risk Communication Advisory Committee; Notice of Meeting
	10/11/2012	Notice.	Neurological Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	10/05/2012	Notice.	Request for Notification From Industry Organizations Interested in Participating in the Selection Process for Nonvoting Industry Representatives and Request for Nominations for Nonvoting Industry Representatives on the Tobacco Products Scientific Advisory Committee
	10/05/2012	Notice.	Request for Nominations for Voting Members on Public Advisory Committees
	10/05/2012	Notice.	Request for Nominations for Voting Members on a Public Advisory Committee; Tobacco Products Scientific Advisory Committee
	10/03/2012	Notice.	Clinical Investigator Training Course
	09/28/2012	Notice.	Gastrointestinal Drugs Advisory Committee; Notice of Postponement of Meeting
	09/27/2012	Notice of public workshop.	Food Defense; Public Workshop
	09/26/2012	Notice.	Anti-Infective Drugs Advisory Committee; Notice of Meeting
	09/20/2012	Notice.	Oncologic Drugs Advisory Committee; Notice of Meeting
	09/20/2012	Notice.	Anti-Infective Drugs Advisory Committee; Notice of Meeting
	09/18/2012	Notice.	Science Advisory Board to the National Center for Toxicological Research; Notice of Meeting
	09/17/2012	Notice.	Pediatric Oncology Subcommittee of the Oncologic Drugs Advisory Committee; Notice of Meeting
	09/13/2012	Notice of public workshop.	Food and Drug Administration/American Glaucoma Society Workshop on the Validity, Reliability, and Usability of Glaucoma Imaging Devices
	09/11/2012	Notice.	Science Board to the Food and Drug Administration: Request for Nominations
	09/11/2012	Notice.	Anti-Infective Drugs Advisory Committee; Notice of Meeting
	08/30/2012	Notice.	Nonprescription Drugs Advisory Committee; Notice of Meeting
	08/30/2012	Notice of meeting.	Food and Drug Administration/European Medicines Agency Orphan Product Designation and Grant Workshop
	07/19/2012	Notice.	Ophthalmic Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	07/18/2012	Notice.	Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	07/18/2012	Notice.	Vaccines and Related Biological Products Advisory Committee; Notice of Meeting
	07/17/2012	Notice of public workshop.	Use of Influenza Disease Models To Quantitatively Evaluate the Benefits and Risks of Vaccines: A Technical Workshop; Public Workshop
	07/16/2012	Notice.	Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting
	07/13/2012	Notice of public conference.	Food and Drug Administration/Xavier University Global Outsourcing Conference
	07/10/2012	Notice.	Anti-Infective Drugs Advisory Committee; Notice of Meeting
	06/25/2012	Notice.	Oncologic Drugs Advisory Committee; Amendment of Notice
	06/21/2012	Notice.	Gastrointestinal Drugs Advisory Committee; Notice of Meeting
	06/19/2012	Notice.	Dermatologic and Ophthalmic Drugs Advisory Committee; Notice of Meeting
	06/14/2012	Notice of meeting.	Update to Electronic Common Technical Document Module 1
	05/31/2012	Notice.	Oncologic Drugs Advisory Committee; Notice of Meeting
	05/31/2012	Notice.	Orthopaedic and Rehabilitation Devices Panel of the Medical Devices Advisory Committee; Amendment of Notice
	05/24/2012	Notice of public workshop.	Use of Computer Simulation of the United States Blood Supply in Support of Planning for Emergency Preparedness and Medical Countermeasures; Public Workshop
	05/24/2012	Notice of meeting.	Requirements for Importing Food and Drug Administration Regulated Products Into the United States
	05/24/2012	Notice.	Oncologic Drugs Advisory Committee; Notice of Meeting
	05/24/2012	Notice.	Risk Communication Advisory Committee; Notice of Meeting
	05/18/2012	Notice.	Blood Products Advisory Committee; Notice of Meeting
	05/08/2012	Notice.	Gastrointestinal Drugs Advisory Committee; Cancellation
	05/07/2012	Notice of public workshop.	Food and Drug Administration/International Society for Pharmaceutical Engineering Cosponsorship Educational Workshop: Redefining the `C' in CGMP: Creating, Implementing, and Sustaining a Culture of Compliance
	05/07/2012	Notice of public workshop.	Educational Forum on Medical Device Reporting, Complaint Files, and Recalls, Corrections, and Removals; Public Workshop
	04/27/2012	Notice.	Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	04/27/2012	Notice.	Oncologic Drugs Advisory Committee; Notice of Meeting
	04/25/2012	Notice of conference.	The 15th Annual Food and Drug Administration-Orange County Regulatory Affairs Educational Conference in Irvine, CA; “Sustainable Regulatory Practices”
	04/12/2012	Notice.	Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting
	04/12/2012	Notice.	Request for Notification From Industry Organizations Interested in Participating in the Selection Process for Nonvoting Industry Representative on the Blood Products Advisory Committee, and Request for Nominations for Nonvoting Industry Representatives on the Blood Products Advisory Committee
	04/11/2012	Notice of meeting.	Medical Countermeasures Initiative Regulatory Science Symposium
	04/05/2012	Notice.	Blood Products Advisory Committee; Notice of Meeting
	04/05/2012	Notice.	General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	04/03/2012	Notice.	Peripheral and Central Nervous System Drugs Advisory Committee; Notice of Meeting
	04/02/2012	Notice.	Pediatric Advisory Committee; Notice of Meeting
	03/28/2012	Notice.	Gastroenterology and Urology Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	03/27/2012	Notice of public workshop.	Development of Animal Models of Pregnancy To Address Medical Countermeasures for Influenza in the “At Risk” Population of Pregnant Women: Influenza as a Case Study; Public Workshop
	03/26/2012	Notice.	Antiviral Drugs Advisory Committee; Notice of Meeting
	03/23/2012	Notice.	Gastrointestinal Drugs Advisory Committee; Notice of Meeting
	03/21/2012	Notice of meetings.	Standards for Private Laboratory Analytical Packages and Introduction to Laboratory Related Portions of the Food Modernization Safety Act for Private Laboratory Managers
	03/19/2012	Notice.	Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting
	03/19/2012	Notice.	Circulatory System Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	03/13/2012	Notice of public workshop.	Public Workshop on Minimal Residual Disease; Public Workshop
	03/12/2012	Notice of public meeting.	Preparation for International Conference on Harmonization Steering Committee and Expert Working Group Meetings in Fukuoka, Japan; Regional Public Meeting
	03/12/2012	Notice.	Arthritis Advisory Committee; Notice of Meeting
	03/09/2012	Notice of meeting.	Preparation for International Cooperation on Cosmetics Regulations; Public Meeting
	03/07/2012	Notice.	Arthritis Advisory Committee; Notice of Meeting
	03/05/2012	Notice.	Advisory Committees; Filing of Closed Meeting Reports
	02/29/2012	Notice of public workshop.	Food Labeling Workshop; Public Workshop
	02/28/2012	Notice.	Radiological Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	02/28/2012	Notice.	Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting
	02/28/2012	Notice.	Joint Meeting of the Anti-Infective Drugs Advisory Committee and the Nonprescription Drugs Advisory Committee; Notice of Meeting
	02/23/2012	Notice.	Request for Nominations for Voting Members on a Public Advisory Committee; Risk Communication Advisory Committee
	02/22/2012	Notice of public conference.	Food and Drug Administration/Xavier University Global Medical Device Conference
	02/15/2012	Notice of public workshop.	Food and Drug Administration Clinical Trial Requirements, Regulations, Compliance, and Good Clinical Practice
	02/13/2012	Notice.	Tobacco Products Scientific Advisory Committee; Notice of Meeting
	02/13/2012	Notice.	Neurological Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
	02/13/2012	Notice.	Request for Notification From Consumer Organizations Interested in Participating in the Selection Process for Nominations for Voting and/or Nonvoting Consumer Representatives and Consumer Representatives on Public Advisory Committees or Panels
	02/13/2012	Notice.	Gastrointestinal Drugs Advisory Committee; Notice of Meeting
	02/13/2012	Notice.	Blood Products Advisory Committee; Cancellation
	02/09/2012	Notice.	Advisory Committee for Reproductive Health Drugs; Notice of Meeting
	02/08/2012	Notice.	Endocrinologic and Metabolic Drugs Advisory Committee; Notice of Meeting
	02/06/2012	Notice.	Oncologic Drugs Advisory Committee; Notice of Meeting
	02/03/2012	Notice.	Oncologic Drugs Advisory Committee; Notice of Meeting
	01/30/2012	Notice of public conference.	Annual Computational Science Symposium; Public Conference
	01/30/2012	Notice.	Blood Products Advisory Committee; Notice of Meeting
	01/30/2012	Notice.	Pulmonary-Allergy Drugs Advisory Committee; Notice of Meeting
	01/25/2012	Notice.	Vaccines and Related Biological Products Advisory Committee; Notice of Meeting
	01/11/2012	Notice.	Arthritis Advisory Committee; Notice of Meeting
	01/11/2012	Notice.	Advisory Committee for Pharmaceutical Science and Clinical Pharmacology; Notice of Meeting
View More Docket Documents

Enhanced Content - Related Documents

Public Comments
Enhanced Content - Public Comments

This feature is not available for this document.

Enhanced Content - Public Comments
Regulations.gov Data
Enhanced Content - Regulations.gov Data

Additional information is not currently available for this document.

Enhanced Content - Regulations.gov Data
Sharing
Enhanced Content - Sharing

Shorter Document URL

https://www.federalregister.gov/d/2012-23885

Email

Email this document to a friend

Enhanced Content - Sharing
Print
Enhanced Content - Print
- Print this document
Enhanced Content - Print
Document Statistics
Enhanced Content - Document Statistics

Document page views are updated periodically throughout the day and are cumulative counts for this document. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.

Page views

153 as of 08/10/2026 at 2:15 am EDT

Enhanced Content - Document Statistics
Other Formats
Enhanced Content - Other Formats

This document is also available in the following formats:

JSON

Normalized attributes and metadata

XML

Original full text XML

MODS

Government Publishing Office metadata

More information and documentation can be found in our developer tools pages.

Enhanced Content - Other Formats
Public Inspection
Public Inspection

This PDF is FR Doc. 2012-23885 as it appeared on Public Inspection on 09/27/2012 at 8:45 am.

If you are using public inspection listings for legal research, you should verify the contents of the documents against a final, official edition of the Federal Register. Only official editions of the Federal Register provide legal notice of publication to the public and judicial notice to the courts under 44 U.S.C. 1503 & 1507. Learn more here.

Public Inspection

Published Document: 2012-23885 (77 FR 59624)

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Document Headings

Document headings vary by document type but may contain the following:

the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions

See the Document Drafting Handbook for more details.

Department of Health and Human Services

Food and Drug Administration

[Docket No. FDA-2012-N-0001]

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is postponing the Gastrointestinal Drugs Advisory Committee Meeting scheduled for October 15, 2012. This meeting was announced in the Federal Register of August 16, 2012 (77 FR 49446). The postponement is due to scheduling issues.

FOR FURTHER INFORMATION CONTACT:

Cindy Hong, Center for Drug Evaluation and Research, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 31, Rm. 2417, Silver Spring, MD 20993-0002, 301-796-9001, Fax: 301-847-8533, email: GIDAC@fda.hhs.gov, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), or visit our Web site at http://www.fda.gov/AdvisoryCommittees/default.htm.

Dated: September 25, 2012.

Jill Hartzler Warner,

Acting Associate Commissioner for Special Medical Programs.

[FR Doc. 2012-23885 Filed 9-27-12; 8:45 am]

BILLING CODE 4160-01-P

Published Document: 2012-23885 (77 FR 59624)

Notice

Gastrointestinal Drugs Advisory Committee; Notice of Postponement of Meeting

Department of Health and Human Services

Food and Drug Administration

AGENCY:

ACTION:

SUMMARY:

FOR FURTHER INFORMATION CONTACT:

Home

Sections

Browse

Search

Reader Aids

My FR

Information